healthy choice glp-1 meals Plated Conagra Brands eyes GLP-1 users

Some formulations also carry indications for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

GLP-1s still account for a relatively small share of the total number of Medicaid prescriptions, accounting for about 1% of all Medicaid prescriptions in 2024 (up from about 0% in 2019)

But in such a new field of research, customers of these weight-loss startups are essentially test subjects, says Chastain: "The danger to consumers is that they take on risk and expensive medication based on a claim that is not scientifically basedthat's not evidence-based." Startups, by nature, exist to fix problems

Oral Semaglutide and Cardiovascular Outcomes in Patients With Type 2 Diabetes